ReviewPatient preference and adherence2014

Two decades of subcutaneous glatiramer acetate injection: current role of the standard dose, and new high-dose low-frequency glatiramer acetate in relapsing-remitting multiple sclerosis treatment.

Matteo Caporro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.